Abstract
Background:
Human adenovirus 36 (Adv36) is associated with obesity in children. Most prior studies have been small and the association of Adv36 status with markers of metabolic risks has been inconsistent.
Objectives:
To determine the prevalence of Adv36 antibodies in different weight categories of adolescents and to evaluate the association of Adv36 infection with anthropometric parameters and cardiometabolic health risks.
Subjects and methods:
In 1179 Czech adolescents (85 underweight, 506 normal weight, 160 overweight and 428 obese), the following variables were evaluated: anthropometric (body weight, height, body mass index, circumferences, fat mass), blood pressure, biochemical and hormonal (lipid profile, glucose, insulin, liver enzymes, adiponectin) and Adv36 antibodies (enzyme-linked immunosorbent assay).
Results:
Of the total cohort, 26.5% were positive for Adv36 antibodies (underweight: 22.3%; normal weight: 21.5%; overweight: 40.0% and obese: 28.0%). The odds ratio for Adv36 antibody positivity evaluated vs normal weight was 2.61 for overweight (95% confidence interval (CI): 1.77–3.86, P<0.001) and 1.46 for obesity (95% CI: 1.07–1.99, P=0.016). A significantly higher prevalence of Adv36 infection was observed in female subjects (32.5%) in comparison to male subjects (19.7%; P<0.001). Adv36 positivity of the whole cohort was significantly related to body weight (P=0.042), body mass index (P=0.015), hip circumference (P=0.004), body height z-score (P=0.029), and total body fat (P=0.000) and trunk fat (P=0.000). Adv36 antibody-positive girls demonstrated significantly higher body height (167.8 vs 165.0 cm, P=0.01) and waist circumference (77.0 vs 72.0 cm, P=0.01). Infected adolescents exhibited significantly higher levels of total cholesterol (TC) and low-density lipoprotein cholesterol (LDL-C), but lower levels of blood glucose. Liver enzymes were significantly increased only in Adv36-positive boys.
Conclusion:
These results demonstrated an association of Adv36 antibodies with obesity and an even greater association with overweight. Adv36 positivity was related to increased fat mass, levels of TC and LDL-C, but to decreased level of blood glucose. No relation to adiponectin levels was revealed.
Similar content being viewed by others
References
Lobstein T, Baur L, Uauy R, IASO International Obesity Task Force. Obesity in children and young people: a crisis in public health. Obes Rev 2004; 5 (Suppl 1): 4–104.
McAllister EJ, Dhurandhar NV, Keith SW, Aronne LJ, Barger J, Baskin M et al. Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr 2009; 49: 868–913.
Dhurandar NV . Infectobesity: obesity of infectious origin. J Nutr 2001; 131: 2794S–2797S.
Pasarica M, Mashtalir N, McAllister EJ, Kilroy GE, Koska J, Permana P et al. Adipogenic human adenovirus Ad-36 induces commitment, differentiation, and lipid accumulation in human adipose-derived stem cells. Stem Cells 2008; 26: 969–978.
Atkinson RL, Dhurandhar NV, Allison DB, Bowen RL, Israel BA, Albu JB et al. Human adenovirus AD-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes (Lond) 2005; 29: 281–286.
Yamada T, Hara K, Kadowaki T . Association of adenovirus 36 infection with obesity and metabolic markers in humans: a meta-analysis of observational studies. PLoS One 2012; 7: e42031.
Almgren M, Atkinson R, He J, Hilding A, Hagman E, Wolk A et al. Adenovirus-36 is associated with obesity in children and adults in Sweden as determined by rapid ELISA. PLoS One 2012; 7: e41652.
Atkinson RL . Prevalence of infection with adenovirus-36 in Belgium and Holland and association with obesity. Obesity (Silver Spring, MD) 2011; 19: 2.
Trovato GM, Castro A, Tonzuso A, Garozzo A, Martines GF, Pirri C et al. Human obesity relationship with Ad36 adenovirus and insulin resistance. Int J Obes (Lond) 2009; 33: 1402–1409.
Trovato GM, Martines GF, Garozzo A, Tonzuso A, Timpanaro R, Pirri C et al. AD36 adipogenic adenovirus in human non-alcoholic fatty liver disease. Liver Int 2010; 30: 184–190.
Na HN, Kim J, Lee HS, Shim KW, Kimm H, Jee SH et al. Association of human adenovirus-36 in overweight Korean adults. Int J Obes (Lond) 2012; 36: 281–255.
Goossens VJ, deJager SA, Grauls GE, Gielen M, Vlietinck RF, Derom CA et al. Lack of evidence for the role of human adenovirus-36 in obesity in a European cohort. Obesity (Silver Spring, MD) 2011; 19: 220–221.
Broderick MP, Hansen CJ, Irvine M, Metzgar D, Campbell K, Baker C et al. Adenovirus 36 seropositivity is strongly associated with race and gender, but not obesity, among US military personnel. Int J Obes (Lond) 2010; 34: 302–308.
Atkinson RL, Lee I, Shin HJ, He J . Human adenovirus-36 antibody status is associated with obesity in children. Int J Pediatr Obes 2010; 5: 157–160.
Na HN, Hong YM, Kim J, Kim HK, Jo I, Nam JH . Association between human adenovirus-36 and lipid disorders in Korean schoolchildren. Int J Obes (Lond) 2010; 34: 89–93.
Gabbert C, Donohue M, Arnold J, Schwimmer JB . Adenovirus 36 and obesity in children and adolescents. Pediatrics 2010; 126: 721–726.
Dhurandhar NV, Israel BA, Kolesar JM, Mayhew G, Cook ME, Atkinson RL . Transmisibility of adenovirus-induced adiposity in a chicken model. Int J Obes 2001; 25: 990–996.
Trovato GM, Martines GF, Trovato FM, Pirri C, Pace P, Garozzo A et al. Adenovirus-36 seropositivity enhances effects of nutritional intervention on obesity, bright liver, and insulin resistance. Dig Dis Sci 2012; 57: 535–544.
Trovato GM, Martines GF, Garozzo A, Tonzuso A, Timpanaro R, Pirri C et al. AD36 adipogenic adenovirus in human non-alcoholic fatty liver disease. Liver Int 2010; 30: 184–190.
Kobzova J, Vignerova J, Blaha P, Krejcovsky L, Riedlova J . The 6th nationwide anthropological survey of children and adolescents in the Czech Republic in 2001. Cent Eur J Public Health 2004; 12: 126–130.
Report of a WHO Expert Committee. Physical status: the use and interpretation of anthropometry. World Health Organ Tech Rep Ser 1995; 854: 429–431.
Bergman RN, Stefanovski D, Buchanan TA, Sumner AE, Reynolds JC, Sebring NG et al. A better index of body adiposity. Obesity (Silver Spring, MD) 2011; 19: 1083–1089.
Haas GM, Liepold E, Schwandt P . Percentile curves for fat patterning in German adolescents. World J Pediatr 2011; 7: 16–23.
Zamrazilová H, Hlavatý P, Dušátková L, Sedláčková B, Aldhoon Hainerová I, Kunešová M et al. A new simple method for estimating trunk and visceral fat by bioelectrical impedance: comparison with magnetic resonance imaging and dual X-ray absorptiometry in Czech adolescents. Cas Lek Cesk 2010; 149: 417–422.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescent. The fourth report on the diagnosis, evaluation and treatment of high blood pressure in children and adolescents. Pediatrics 2004; 114: 555–576.
Chapman SJ, Hill AVS. Human genetic susceptibility to infectious disease. Nat Rev Genet 2012; 13: 175–188.
James CB, Vanderpool EA, Roane P . Acceleration of adenovirus replication and increased virion production by treatment with the steroid hormone 17 beta-estradiol. Microbiol Immunol 1992; 36: 99–103.
Vindrieux D, Le Corre L, Hsieh JT, Métivier R, Escobar P, Caicedo A et al. Coxsackie and adenovirus receptor is a target and a mediator of estrogen action in breast cancer. Endocr Relat Cancer 2011; 18: 311–321.
Wolfrum N, Greber UF . Adenovirus signalling in entry. Cell Microbiol 2013; 15: 53–62.
Rogers PM, Mashtalir N, Rathod MA, Dubuisson O, Wang Z, Dasuri K et al. Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36. Diabetes 2008; 57: 2321–2331.
Acknowledgements
This study was supported by the grant: NT/13792-4 Internal Grant Agency of the Ministry of Health of the Czech Republic.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Dr R Atkinson is the owner and Dr Z Lee is Laboratory Director of Obetech, LLC, a company that provides assays for adenoviruses associated with obesity and has several patents in the area of virus-induced obesity. Dr Atkinson also is Co-Editor of the International Journal of Obesity. Dr IA Hainerová, Dr H Zamrazilová, Dr L Dušátková, Dr B Sedláčková, Dr P Hlavatý, Dr M Kunešová and Dr V Hainer declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Aldhoon-Hainerová, I., Zamrazilová, H., Atkinson, R. et al. Clinical and laboratory characteristics of 1179 Czech adolescents evaluated for antibodies to human adenovirus 36. Int J Obes 38, 285–291 (2014). https://doi.org/10.1038/ijo.2013.72
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ijo.2013.72
- Springer Nature Limited
Keywords
This article is cited by
-
Adenovirus 36 prevalence and association with human obesity: a systematic review
International Journal of Obesity (2021)
-
Modulating effect of vitamin D status on serum anti-adenovirus 36 antibody amount in children with obesity: National Food and Nutrition Surveillance
BMC Pediatrics (2020)
-
Obesity and Diabetes in an Arab population: Role of Adenovirus 36 Infection
Scientific Reports (2020)
-
What we know and what we need to know about adenovirus 36-induced obesity
International Journal of Obesity (2020)
-
Ileal transcriptome analysis in obese rats induced by high-fat diets and an adenoviral infection
International Journal of Obesity (2019)